未登录 Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients Mato, A. R.; Hill, B. T.; Lamanna, N.; Barr, P. M.; Ujjani, C. S.; Brander, D. M.; Howlett, C.; Skarbnik, A. P.; Cheson, B. D.; Zent, C. S.; Pu, J. J.; Kiselev, P.; Foon, K.; Lenhart, J.; Bachow, S. Henick; Winter, A. M.; Cruz, A. -L.; Claxton, D. F.; Goy, A.; Daniel, C.; Isaac, K.; Kennard, K. H.; Timlin, C.; Fanning, M.; Gashonia, L.; Yacur, M.; Svoboda, J.; Schuster, S. J.; Nabhan, C. 分享 收藏
Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia Mato, Anthony R.; Foon, Kenneth A.; Feldman, Tatyana; Schuster, Stephen J.; Svoboda, Jakub; Chow, Kar Fai; Valentinetti, Marisa; Mrkulic, Mary; Azzollini, Kelly; Gadaleta, Gabriella; Bhattacharyya, Pritish K.; Zenreich, Joshua; Pascual, Lauren-Nicole; Yannotti, Kara; Kdiry, Sabrina; Howlett, Christina; Strelec, Lauren; Porter, David; Bejot, Coleen; Goy, Andre 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Radioisotopic Localization of 90Yttrium-Ibritumomab Tiuxetan in Patients with CD20+Non-Hodgkin's Lymphoma Jacobs, S. A.; Harrison, A. M.; Swerdlow, S. H.; Foon, K. A.; Avril, N.; Vidnovic, N.; Joyce, J.; DeMonaco, N.; McCarty, K. S., Jr. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase IISWOG TRIAL 9706 环磷酰胺联合氟达拉滨治疗未经治疗的慢性淋巴细胞白血病: 一项IISWOG期试验9706 Hussein, MA; Gundacker, H; Head, DR; Elias, L; Foon, KA; Boldt, DH; Dobin, SM; Dakhil, SR; Budd, GT; Appelbaum, FR 分享 收藏
分享 收藏
分享 收藏